Brief: Theralase Phase IB NMIBC Clinical Study Published
21/06/2022 14:48
June 21 (Reuters) - Theralase Technologies Inc TLT.V :
* THERALASE® PHASE IB NMIBC CLINICAL STUDY PUBLISHED
Source text for Eikon: ID:nGNXxMS3q
Further company coverage: TLT.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Theralase Technologies
See all newsBrief: Theralase Releases FY2022 Audited Financial Statements
Brief: Theralase Commences $CAN 2.5 M Follow-On Private Placement Equity Financing
Brief: Theralase Closes $2.5 Mln Private Placement Equity Financing
Brief: Theralase Phase IB NMIBC Clinical Study Published
Brief: Theralase® Demonstrates Proof-Of-Concept For Canadian-Made COVID-19 Vaccine